| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/17/2006 | US6987116 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987106 Nootropic agents; Alzheimer's Disease, Schizophrenia; ligands for the a7 subunits of the nicotinic receptor; 4-Bromophenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate |
| 01/17/2006 | US6987014 Isolated nucleic acid molecules encoding human drug metabolizing proteins |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987001 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 01/17/2006 | US6986888 Method for treating mammals with modified mammalian blood |
| 01/17/2006 | CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 01/17/2006 | CA2338792C Rapidly disintegrable solid preparation |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/17/2006 | CA2138930C Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds |
| 01/17/2006 | CA2118812C 5-ht4 receptor antagonists |
| 01/17/2006 | CA2086425C Fibroblast growth factor receptors |
| 01/12/2006 | WO2006004115A1 Remedy for hyperactive bladder |
| 01/12/2006 | WO2006004105A1 Method of producing peptide mixture, method of producing fermented milk containing antihypertensive peptide and method of producing antihypertensive peptide preparation |
| 01/12/2006 | WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | WO2006003290A2 Sulphated depolymerised derivatives of exopolysaccharides (eps), preparation and uses thereof |
| 01/12/2006 | WO2006003289A2 Sulphated polysaccharide derivatives for modulating angiogenesis |
| 01/12/2006 | WO2006002453A2 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 01/12/2006 | US20060009534 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009521 Lipoxin analogs as novel inhibitors of angiogenesis |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | US20060009514 Method for treating obesity |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009502 Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| 01/12/2006 | US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009470 Method for specifically potentiating N-type Ca2+ channel activity |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009439 Novel physiologically active substances |
| 01/12/2006 | US20060009438 Administering steroid (such as estrogen) containing hydrophobic substitutions such as adamantane ring; therapy for Alzheimer's, Parkinson's, huntington's disease; multiple sclerosis; amyotrophic lateral sclerosis; strokes; antiischemic agents |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060009397 New use |
| 01/12/2006 | US20060009390 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/12/2006 | US20060009375 Site-specific drug delivery |
| 01/12/2006 | US20060008574 Galactosyl isomalt, method for production and use thereof |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/12/2006 | CA2572163A1 Pyrazole derivatives |
| 01/12/2006 | CA2572125A1 Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags |
| 01/12/2006 | CA2571822A1 Preventive or therapeutic agent for vascular intimal proliferative disease |
| 01/12/2006 | CA2571440A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 01/12/2006 | CA2570318A1 Biaryl derivatives |
| 01/12/2006 | CA2570224A1 Sulphated depolymerised derivatives of exopolysaccharides (eps), preparation and uses thereof |
| 01/12/2006 | CA2570199A1 Use of highly sulfated polysaccharide derivatives of low molar mass for modulating angiogenesis |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
| 01/11/2006 | EP1614687A1 Process for the preparation of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one derivatives and their application in the synthesis of ivabradine and its pharmaceutically acceptable salts |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |
| 01/11/2006 | EP1614429A1 Lklf/klf2 gene expression promoter |
| 01/11/2006 | EP1614428A1 Drug for preventing or treating angiogenic eye diseases |
| 01/11/2006 | EP1614425A2 Leukotriene receptor antagonist |
| 01/11/2006 | EP1614420A2 Treatment of hypertension, angina and other disorders using (-) amlodipine |
| 01/11/2006 | EP1614419A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 01/11/2006 | EP1614418A1 use of(-)(3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives for treatment of hyperuricaemia |
| 01/11/2006 | EP1613741A1 Perivascular mesenchymal precursor cells |
| 01/11/2006 | EP1613659A1 New monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 01/11/2006 | EP1613335A1 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 01/11/2006 | EP1613306A1 Decreasing the incidence of atrial fibrillation (af) in patients with left ventricular dysfunction with ace inhibitors or angiotensin ii receptor antagonists |
| 01/11/2006 | EP1613301A1 Use of l-carnitine for the treatment of cardiovascular diseases |
| 01/11/2006 | EP1613298A2 Lysophosphatidic acid analogs and inhibition of neointima formation |
| 01/11/2006 | EP1613268A2 Methods for inhibition of angiogenesis |
| 01/11/2006 | EP1469887A4 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/11/2006 | EP1435986A4 Igf-binding protein-derived peptide or small molecule |
| 01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 01/11/2006 | EP1395572B1 Process for preparing a thiazole ppar-ligand and polymorphs thereof |
| 01/11/2006 | EP1385489B1 Coated granules based on angiotensin-converting enzyme inhibitor |
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | EP1131315B1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720265A Chitosan-containing polysaccharide, method for preparing the same and use thereof |
| 01/11/2006 | CN1720243A Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 01/11/2006 | CN1720231A Substituted dihydrophenanthridinesulfonamides |
| 01/11/2006 | CN1720062A Therapeutic uses of beta-casein A<2> and dietary supplement containing beta-casein A<2> |
| 01/11/2006 | CN1720049A Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1718231A Medicine composition for treating acute ischemic apoplexia ,and prepn. method therefor |
| 01/11/2006 | CN1718230A Freeze-drying powder injection made of traditional medicine for treating hemorrhoids, and its prepn. method |
| 01/11/2006 | CN1718229A Traditional Chinese medicine for treating coronary heat disease and angina cordis, and its prepn. method |
| 01/11/2006 | CN1718224A Formation of medicine for treating cerebrovascular disease and ear diseases and preparing process |
| 01/11/2006 | CN1718216A Method for increasing content of flavone in extracting ginkgo leaves by using affinity ultrafiltration |
| 01/11/2006 | CN1718213A Patent traditional Chinese medicine for treating and preventing diseases such as high blood-fat, coronary heart disease, hardening of arteries etc. |
| 01/11/2006 | CN1718205A Traditional Chinese herb medicine for preventing and treating cardiovascular diseases |
| 01/11/2006 | CN1718202A Prescription of Chinese herb medicine for nourishing-heart replenishing-qi, and Chinese patent drug or Chinese herb medicine drink therefrom |